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THE INFLUENCE OF CORTICOSTEROIDS AND TOPICAL INDOMETHACIN 
ON SUNBURN ERYTHEMA 
KAVS H. KAIDBEV . M.D. -, AND AM A!. K . KURBAN . M .D. 
Division of Dermatology. Department of Internal Medicine. American University Hospital . Beirut, Lebanon 
The ext.ent to which topical and intradermal corticosteroids and topical indomethacin 
suppress sunburn erythema was investigated in human volunteers. Both agents retarded the 
onset and decreased the magnitude of delayed erythema. Suppression by conicosteroids was 
not demonstrable with ultraviolet doses larger than 2 MEDs (minimal erythema dose) . Below 
2 MEDs, topical betamethasone valerate produced a dose·related suppression of erythema. 
Indomethacin was more effective and produced a measurable dose·dependent suppression 
against 3 and 6 MEDs. Despite significant inhibition of erythema. sunburn damage to 
epidermal cells was not altered by these drugs. 
The moderation of ultraviolet (UV)·induced ery· 
thema has been proposed as a useful means for 
evaluating systemic and topically administered 
drugs with anti ·inflammatory properties 11 -31. 
Recently. these UV·suppression assays were 
adapted for the measurement of anti-inOamma-
tory activity of topical corticosteroid preparations 
14J . Although they are ineffective in guinea pigs 13, 
5,6 J. corticosteroids are capable of modifying UV 
erythema in human skin_ The extent and degree to 
which this is brou~ht about. however_ has been 
poorly documented. It is not known. for instance. 
at what V·dosage level steroids exert their sup-
pressive effect and whether the response is dose 
dependent. Not only is such information essential 
for a proper interpretation of these assays, but it 
may also shed light on the mechanism by whi ch 
steroids produce this effect. Jarvinen IiJ studied 
the influence of systemic steroids on U\' erythema. 
He exposed 14 patients with various systemic 
afflictions to increments of UV light before and 
du ring massive oral doses of cortisone. The mini · 
mal erythema dose (MED I was approximately 
doubled. while the intensity of redness following 
large UV doses was lessened. These values reverted 
to pretreatment levels upon discontinua tion of 
cortisone. Snyder and Eaglstein 151 found that the 
intradermal injection of 125 ~g of t riamcinolone 
acetonide decreased the erythema produced by a 
single exposure to 2.5 MEDs. They observed that 
redness could be totally prevented if the steroid 
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was administered before erythema became appar· 
ent. 
The influence of topical st.eroids is less clear . 
Stoughton 18J mentioned that the occlusive appli. 
cation of topical corticosteroids immediately after 
irradiation suppressed the subsequent erythema 
from 5 MEDs. In contrast. Burdick et al 141 
expressed the belief that doses in excess of 1 MED 
were inadequate for differentiating the various 
topical steroid preparations in the UV.suppression 
assay. while 3 MEDs com pletely eliminated the 
corticosteroid effect. Ljunggren and Moller 191 
found t hat alcoholic solutions of hydrocortisone 
and betamethasone valerate applied before irradi· 
ation were equally efficacious in inhibiting the 
erythema from 1 and 1.5 MEDs. 
More recently. 8 nonsteroidal anti.inflammat.ory 
agent. indomethacin. was shown to suppress U\' 
erythema in both huma ns and guinea pigs 151 . A 
single topical application of a 2.5"( concent ration 
produced blanching of erythema from 2.5 MEDs 
1101. In this regard , it was superior to a potent 
topical corticosteroid formulat ion . 
The present investigation was undertaken to 
compare the efficacy of corticosteroids and topical 
indomethacin in suppressing sunburn erythema 
and to determine whether suppression was dose 
related . In addition . we wished to find out whether 
the e agents could also modify the other acute 
effects of sunburn . 
MATERtALS Al'D METHODS 
Light S ource 
A bank of four 2O-watt FS 20 fluorescent sunlamp 
tubes . housed in a reflector . served as the source of 
sunburning UV (UV-B. 290- 230 nm ) . 
Subjects 
These were healthy white volunteers. ranging in age 
between 21 and 30 years . Informed consent ..... as obtained. 
The MED ..... as determined on the untanned midback of 
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each subject by irradiat.ing I·cm squares with IS-sec 
increments. sLarting with 45 sec. The source-lo-skin 
distance was 14 em. The MED was that dose which 
produced uniform visible erythema, 24 hr later . 
Corticosteroids 
Intmderma l injections. Triamcinolone hexacetonide 
(Aristospan. Lederlel was dilu ted in physiologic saline to 
8 concentration of 2.5 mg/ mi and used for intradermal 
injection. Squares (0,6 em) were outlined with white ad-
hesive tape over the midback of each of 9 subjects a nd 
irradiated with 1. 2. and 3 MEDs. Immediately following 
irradiation. each square. as well as 8 n adjoining area of 
unirradiat.ed skin. was injected with 0.05 ml of the cort i-
costeroid suspension. A duplicBte set of similarly irradi-
ated squares received 0.05 ml of physiologic sa line. The 
sites were graded a t 6 and 24 hr. 
Topical applications. Bel.amethasone valerate powder 
(Schering) was dis.<iolved in ab~olute ethanol to the 
desired concentrat ions. A grid consisting of 4 horizontal 
and 4 vertical rows of O.S·cm squares was outlined on t.he 
untanned mid back of each of 10 subjects by means of thin 
strips of white adhesive t.ape. Horizontal rows were 
irradiated with 1. 2. 3. and 4 MEDs, respectively. 
Immediately following irrad iation. vertical rows received 
10 J.l1 per square of 0.0 1 ~ , 0_05%. and 0.25 % betametha-
sone valerate. One row received absolute ethanol (con-
t rol). The si tes were allowed to dry (5 min) and then 
covered with overlapping strips of impermeable plast ic 
tape (Blenderm. 3M ). Reactions were evaluated 24 hr 
later . 
Topical Indomethacin 
Different concent rations of indomethacin were pre-
pared in a base composed of propylene glycol:ethanol: 
dimethylformamide I: 1:2 v/v. Two rows of 6 0.5-em 
squares were outlined with tape over the untanned backs 
of 10 subjects and exposed to 3and 6 MEDs. respectively. 
Immediately afterwards, vertical rows received 10/-1 1 per 
square of 0.1 ~ . 0.5%. 1.0%. and 2.5 1?f indomethacin. One 
set of control si tes received the base alone and one was 
left unt reated. All sites were left uncovered . Grading was 
done 6 and 24 hr later. 
Hist ology 
Three 4-mm punch biopsies were ob tained from each 
of 3 subjects 24 hr after irradiation with 2 MEDs. The 
specimens were secured from unt reated irradiated skin 
and from sites blanched with 0.25% betamethasone 
valerate and 2.5%: indomethacin. These were fixed in 10% 
formalin. processed routinely. sectioned serially. and 
stained with hematoxyl in- eosin. A crude estimate of 
epidermal damage ..... as made by counting the number of 
sunburn cells. At least 20 sections from each biopsy were 
examined. and the average number of sunburn cells per 
high-power field (HPF) was determined for each speci-
men . 
Grading System 
The intensity of erythema was graded by one of us on a 
4-point scale as follows: O. no erythema ; 1. minimal 
erythema : 2, more pronounced erythema; 3, intense and 
deep erythema. Blanching was graded as follows: O. no 
visible blanching ; 1. faint blanch ; 2, more definit.e 
blanch; 3. int.ense blanch_ 
Analysis of sign ificance was done by using the i·test for 
paired observations. 
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RESULTS 
Intradermal injection , A single dose of 125 ~g of 
triamcinolone hexacetonide produced significant 
suppression of erythema from 1 and 2 MEDs at 6 hr 
(p < O.OI). Suppression was much less pro-
nounced , however, by 24 hr: was significant only 
against 1 MED (Tab .); and only the erythema 
from 1 MED could be totally prevented. Thi s 
occurred in 4 of 9 subjects, Blanching was evident 
in sites injected with the steroid . and often sur-
rou nded the ir radiated erythematous squa re. 
Blanching was more intense at 6 hr (mean score 
2.7) than at 24 hr (mean score 1.1) . 
Topical betamethasane valerate. At a 0.0 1 % 
concentration, the drug had no effect whatever at 
any UV -dose level. Higher concen trations pro-
duced a dose-related suppression of erythem a 
against 1 and 2 MEDs (Fig. 1). No significant 
suppress ion occurred against larger UV doses 
within the concentration range studied. Erythema 
could be totally prevented only with 1 MED . 
Blanching in the immediate surrounding skin was 
TARLE . Inh ibition of eV-8 erythl'ma by intraderma l 
triamcinolone hexacetonide 
The value!' represen t mean erythema scores of triam -
cinolone (THI -t reated s ites and saline cont rols. N 9 
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FIG. 1. Infl uence of t.opical betamethasone valera!.e on 
erythema produced by graded UV exposu res. ·'0" scores 
indicate control values. Regression lines at 1 and 2 MEDs 
were determined by the method of least squares. Each 
value represents the mean of 10 observations (N "" 10). 
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often quite pronoun ced and its intensity paralleled 
the concentration of the drug. 
Topi cal indomethacin. The drug produced a 
dose-related suppression of erythema from both 3 
and 6 MEOs (Fig . 2). At a 0.1 'if concentration, 
there was no measurable response over the control. 
Suppression was more pronounced at 6 than at 24 
hr . In no instance was erythema completely pre· 
vented by 24 hr. The vehicle alone did not produce 
any blanching . 
Histopathology. Sections from sites partially 
blanched with betamethasone and indomethacin 
were indistinguishable from their respective con· 
trois as regards both the extent of epidermal 
damage and severity of the dermal infiltrate. The 
epidermis contained many dyskeratotic epithelial 
cells with eosinophilic staining cytoplasm and 
pyknotic nuclei (sunburn cells). There was diffuse 
interstitial edema and mild perinuclear vacuoliza · 
tion. The dermis showed a predominantly mono· 
nuclear infiltrate around the papillary vessels. The 
avera~e number of sunburn cells per HPF was 
similar in treated and control specimens. 
DlsrusstO~ 
Our findings indicate that cort icosteroids can 
influence sunburni ng: U\· erythema in at least two 
ways . F'irsliy. they dela~' the onset of redness to a 
period beyond 6 hr: secondly. they decrease the 
magnitude of the delayed erythema. These su p-
pressive effects , however. are sharply limited to 
doses of up to 2 M EOs. Larger exposures com-
pletey o\'erride the corticosteroid effect. Erythem a 
could not be totally pre\'ented with doses beyond 1 
MED . These are important considerations when 
UY ·suppression assays are to be used for co mpar-
ing topi cal corticosteroid preparations. \\-e agree 
with Burdick et al that doses in excess of 1 MEO 
are not sufficiently discriminating. Even at this 
level. a 0.01 CY concentration of a potent fluorinated 
cort icosteroid uch as betamethasone valerate 
failed to produce any suppressIOn. \Ve therefore 
FIG. 2. Effect of topical indomethacin on erythema 
produced by 3 and 6 M EDs. Mean scores obtained with 
the O . I ~ concent ration were the same as controls. Each 
value represents the mean of 10 observations ± standard 
error of mean . 
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doubt that such assays are sensitive enough to 
measure weak or moderately active cort icosteroid 
compounds. 
Although corticosteroids are the most potent of 
kn own anti-inflammatory agents, their suppressive 
effect against UV erythema was modest. It may be 
that anti.inflammator.y potency is not uniform but 
varies with the type of noxious stimu\us and 
subsequent inflammatory reaction. On the ot her 
hand, steroids may decrease UV erythema by their 
well -kn own vasoconstrictor action on cutaneous 
vessels in a manner analogous to the blanching 
produced by the injection of epinephrine into 
UV-reddened skin. It is noteworthy that the delay 
in the onset of erythema coincided with the period 
of maximal blanching produ ced by intradermal 
triamcin olone . It has been suggested in the past 
that steroid-induced vasoconstriction may be me-
diated by norepinephrine release III J. 
There are other ways by which steroids may 
influence UV erythema. Weissman and Fell 1I2J 
observed that the addition of hydrocortisone to 
fetal rat skin explants retarded and reduced cellu -
lar breakdown produced by UV light. It is though t 
that UV damage can be brought about by the 
rupture of Iysosomes with the release of hydrolytic 
enzymes \1 3J. The membrane-st.abilizing proper-
ties of corticosteroids may counteract that effect. It 
is not fully clear how important lysosome labiliza · 
tion is in mediating UV injury_ Acute UV damage 
t.o epidermal cells can occur without the rupture of 
these organelles 114). Corticosteroids have also 
been reported to inhibit the biosynthesis and 
release of prostaglandins 115,16 J. 
Topical indomethacin was far more effective 
than corticosteroids. Suppression of erythema was 
readily demonstrable against a relatively large UV 
dose (6 MEOs). Like steroids. it delayed the onset 
and decreased the intensity of redness. Snyder and 
Eaglstein 15J showed that intradermally adminis-
tered indomet hacin produced a dose-related 
blanching of UV- B erythema in humans and 
guinea pigs. The drug is also effective when given 
orally 12,6,17 J. It probably exerts its effect by a 
mechanism different from that of corticosteroids. 
Indomethacin has been shown to inhibit prosta· 
glandin (PC ) biosynthesis by human skin 118J. 
There is mou nting evidence that PCs are likely 
candidates for mediating sunburn erythema. and a 
measurable increase in the amount of PGs occurs 
in skin exposed to UV 119.20J. When injected 
intradermally_ PCE , produces a long- lasting ery-
thema that persists for up to 10 hours. and can be 
blanched by catecholamines 121 J. Indomethacin 
has been shown to block PC production by endo-
thelial cells in "itro 122J. 
Neither corticosteroids nor indomethacin were 
ca pable of altering the extent of acute U\ ' damage 
to epidermal cel ls as judged by light microscopic 
finding. even when erythema was appreciably 
decreased . Snyder 123J also found tha t topical 
indomethacin failed to modify epidermal UV in-
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jury. It would appear that these drugs act primar-
ily on the dermal vasculature. We doubt. therefore. 
that these agents will be of value in diminishing 
the more serious long-term effects of chronic sun 
exposure. 
REFEREN CES 
1. Winder CV. Wax J . Burr V, Been M. Rosiere CE: A 
study of pharmacological influences on ultravio let 
erythema in guinea pigs. Arch lnt Pharmacodyn 
Ther 116:261- 292. 1958 
2. Gruber e M , Ridolfo AS. Nickander R. Mikulaschek 
WM : Delay of erythema of human skin by a nti · 
innammatory drugs after ultraviolet irradiation . 
Clin Pharmacol Ther 13: 109- 113. 1972 
3. Lambelin G, Vassart-Tbys D, Robs J : Pharmacolog-
ical studies of bufexamac topically applied on the 
skin . Arch lot Pharmacodvn Ther 18i :401 - 414. 
1970 . 
4. Burdick KH. Haleblian JK . Poulsen BJ , Coboer SE: 
Corticosteroid ointments: compari son by two 
human bioassays. CUTT Ther Res 15 :233- 242. 1973 
5. Snyder DS. Eaglstpin WH : Intradermal anti -prosta· 
glandin agents and sunburn . J Im'est Derm atol 
62:4.- 50. 1974 
6. Gupta N. Levy L: Delayed manifestation of ultravio-
let react ion In the ~uinea pig caused by anti -
inflammatory drugs. Br J Pharmacol 47:240- 248. 
1973 
7. Jarvinen KAJ: Effec t of cort isone on reaction of skin 
to ultraviolet light. Br Med J 2:1377- 1378. 1951 
8. Stought.on HB: Corticost.eroids in psoriasis. Proceed-
ings of the In te rnational Symposium on Psoriasis. 
Stanford Universi ty. 1971. Edited by EM Farber, 
AJ COX. Stanford. Calif. Stanford University 
Press. 1971 , pp 367-375 
9. Ljunggren B. Moller H: Influence of cort icosteroid on 
ultraviolet light erythema and pigmentation 10 
man. Arch Dermatol Forsch 248: 1- 12. 1973 
to. Snyder DS . Eaglstein WH : Topical indomethacin 
and sunburn . Br J Dermatol 90:91 -93. 1974 
Vol. 66, No.3 
11. Solomon LM . Wentzel HE. Greenberg MS : Studies 
in the mechanism of steroid vasoconstriction . J 
Invest DermatoI44 :129- 131. 1965 
12. Weissman G. Fell HB: Effect of hydrocortisone on 
response of fetal rat skin in culture to ultraviolet 
irradiation. J Exp Med 116:365- 380. 1962 
13. Johnson BE. Daniels F Jr: Lysosomes and the 
reactions of skin to ultraviolet radiation . J Invest 
Dermatol 53:85- 94. 1969 
14 . Honig:smann H. Wolff K. Konrad K: Epidermal 
iysosomes and ultraviolet light. J Invest Dermatol 
63:337- 342. 1974 
15. Greaves MW. McDonald -Gibson W: Inhibition of 
prostaglandin biosynthesis by corticosteroids. Br 
Med J 2:83- 84. 1972 
16. Lewis GP. Pipet PJ : Inhibition of release of prost.a -
glandins as an explanation of some of the actions of 
anti·inflammatorv corticosteroids. Nature (Lond ) 
254: 308-310. 19i5 
17 . Greenberg RA. Eag-lstein WH , Turn ier H, Houdek 
PV : Orally given indometha cin and blood now 
response 1.0 UVL. Arch Dermatollll :328- 330. 1975 
18. Greaves MW. McDonald-Gibson W : Effect of non-
steroid anti.inflammat.ory and antipyretic drugs 
on prostaglandin biosynthesis by human skin. J 
Invest Dermotol 61 :12i- 129. 19i3 
19. Greaves MW. S0ndergaard J : Pharmacologic agents 
released in ultraviolet inflammation studied by 
cont inuous skin perfusion. J Invest Dermatol 
54:365- 36i. 19iO 
20. Mathur GP. Gandhi VM : Proslaglandin in human 
and albino ra t skin. J Invest Dermotol 58:291 - 295. 
1972 
21. Solomon LM . J ohl in L. Kirschenbaum MB: Prosta· 
glandins on cutaneous vascula ture . J Invest Der· 
rnatoI 51 :280-282. 1968 
22. Gimbrone MA. Alexander RW : Angiotensin II stimu· 
lation of prostaglandin product ion in cultured 
human vascular endothelium. Science 189: 219-
220, 1975 
23. Snyder DS : Cutaneous effects of t.opical indometha-
cin , an inhibitOr of prost8J!landin synt hesis. on 
UV-damag-ed skin. J Invest Dermatol 64:322-325. 
1975 
